Articles: 29.09 September 2018

Online consultations: no substitute for face-to-face appointments

Technology is everywhere. Google processes 40,000 queries every second and Facebook has over two billion active users. A third of the world’s population carry a highly sophisticated and powerful computer in their pocket (it’s called a smartphone). Even autonomous cars are no longer the sole preserve of a 1980s David Hasselhoff. But technology is also now trying to revolutionise the way we practise medicine

More details...

Are patients taking pot luck with cannabis?

In July, Home Secretary Sajid Javid decided to reschedule cannabis-derived medicinal products to allow them to be legally prescribed by specialist clinicians. But while there is some scientific evidence supporting the use of cannabinoids in certain medical conditions, more research is needed to determine the full risks and benefits.

More details...

Recommended drug therapies for inflammatory bowel disease

The treatment of inflammatory bowel disease (ulcerative colitis and Crohn’s disease) has been revolutionised in recent years with the advent of biological therapies. This article discusses the current role of both conventional and biological treatments in the management of these conditions

More details...

The NHS at 70: five key questions answered

To mark the NHS’s 70th birthday in July, The Health Foundation, the Institute for Fiscal Studies, The King’s Fund and the Nuffield Trust joined forces to produce a series of five reports examining the state of the NHS and social care in the UK past, present and future. This article summarises some of the key findings of the reports

More details...

Online consultations: the future of NHS GP appointments?

In 2016, the General Practice Forward View invested £45 million in a national programme to support uptake of online consultation systems in every GP practice. This article examines the progress that has been made so far, and whether this new way of working is proving popular with health professionals and patients

More details...

Management of systemic lupus erythematosus in adults

Earlier this year, the British Society for Rheumatology (BSR) published the first UK guideline on the management of systemic lupus erythematosus (SLE) in adults. This article summarises its recommendations on diagnosis, monitoring and treatment

More details...

Ocrelizumab for relapsing or primary progressive MS

Ocrelizumab (Ocrevus) is a new monoclonal antibody treatment for patients with relapsing-remitting multiple sclerosis (RRMS) and for those with early primary progressive multiple sclerosis (PPMS). This article summarises its indications, efficacy and adverse effects

More details...

Reflections on NHS England’s OTC prescribing ban

NHS England’s guidance on conditions for which over the counter items should not routinely be prescribed in primary care was launched in March, amid much controversy. Here, Angus Thompson relays some of his own concerns about the guidance

More details...

Web design and marketing agency Leamington Spa